Jefferies Group’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-4,601
Closed -$212K – 2492
2019
Q4
$212K Buy
+4,601
New +$216K ﹤0.01% 2229
2018
Q2
– Sell
-12,619
Closed -$742K – 2582
2018
Q1
$742K Buy
12,619
+7,692
+156% +$431K ﹤0.01% 1324
2017
Q4
$270K Buy
4,927
+127
+3% +$6.58K ﹤0.01% 2063
2017
Q3
$227K Buy
+4,800
New +$226K ﹤0.01% 2012
2017
Q2
– Sell
-12,531
Closed -$478K – 2457
2017
Q1
$478K Buy
12,531
+6,231
+99% +$231K ﹤0.01% 1608
2016
Q4
$228K Buy
+6,300
New +$239K ﹤0.01% 1869
2015
Q3
– Sell
-179
Closed -$6K – 2812
2015
Q2
$6K Buy
+179
New +$6.16K ﹤0.01% 2952

Other funds holding OFIX

Jefferies Group's OFIX Position: Q1 2020 in Review

Jefferies Group sold out of Orthofix Medical (OFIX) in Q1 2020, closing a stake of 4,601 shares — an estimated $212K sold.

Jefferies Group first reported a position in OFIX in Q2 2015 and held it in 7 quarters. The position peaked at $742K in Q1 2018. 145 funds tracked by Wall St. Rank hold OFIX as of Q1 2020.

  • Jefferies Group reported no remaining Orthofix Medical position as of Q1 2020 after selling out during the quarter.
  • Jefferies Group sold 4,601 Orthofix Medical shares in Q1 2020, an estimated $212K.
  • Jefferies Group first reported a position in Orthofix Medical in Q2 2015 and held it in 7 quarters.
  • Jefferies Group's Orthofix Medical position peaked at $742K in Q1 2018.
  • 145 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2020.

Based on Jefferies Group's 13F filing for Q1 2020, filed 15 May 2020.